Comment
Review: etanercept (25 mg subcutaneously twice weekly) reduces symptoms and disease activity in rheumatoid arthritis
Affiliations
- PMID: 15230563
Item in Clipboard
Comment
Review: etanercept (25 mg subcutaneously twice weekly) reduces symptoms and disease activity in rheumatoid arthritis
ACP J Club.
2004 Jul-Aug.
No abstract available
Comment on
-
Etanercept for the treatment of rheumatoid arthritis.Cochrane Database Syst Rev. 2003;(4):CD004525. doi: 10.1002/14651858.CD004525. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2013 May 31;(5):CD004525. doi: 10.1002/14651858.CD004525.pub2. PMID: 14584021 Updated.